Intensive Surveillance Cost-Effective in Stage II, III CRC
Intensive surveillance after resection on patients with colorectal cancer (CRC) was less cost-effective in stage I but most cost-effective in stage II and III disease.
Stay updated with breaking news from Cost Effectiveness. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Intensive surveillance after resection on patients with colorectal cancer (CRC) was less cost-effective in stage I but most cost-effective in stage II and III disease.
Emma Ciafaloni, MD, FAAN, describes the key differences among viral vectors used in gene therapy, highlighting their applications and strengths in targeting specific diseases.
Experts delve into the fundamentals of gene therapy, covering in vivo and ex vivo methods, and explore cellular function targets for effective treatment of a disease.
Jessica Nance, MD, MS, discusses maximizing gene therapy efficiency by selecting vectors for gene size, tissue targeting, and low exposure, and focusing on precise promoters for expression.
The TOPS device, for lumbar facet arthroplasty, is more cost-effective compared to a transforaminal lumbar interbody fusion when addressing degenerative spondyl